210 related articles for article (PubMed ID: 16086426)
21. Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders.
Borenstein J; Pezzella F; Gatter KC
Histopathology; 2007 Dec; 51(6):774-7. PubMed ID: 17944927
[TBL] [Abstract][Full Text] [Related]
22. Intracranial involvement of posttransplant lymphoproliferative disorder multiple myeloma.
Wilberger AC; Prayson RA
J Clin Neurosci; 2015 Nov; 22(11):1850-1. PubMed ID: 26375326
[TBL] [Abstract][Full Text] [Related]
23. Post-transplant lymphoproliferative disorders of oral cavity.
Ojha J; Islam N; Cohen DM; Marshal D; Reavis MR; Bhattacharyya I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 May; 105(5):589-96. PubMed ID: 18442744
[TBL] [Abstract][Full Text] [Related]
24. Demonstration of Epstein-Barr virus in a case of multiple myeloma after renal transplantation.
Ancín I; Sarrá J; Peris J; Romagosa V; Domingo-Claros A; Grañena A
Haematologica; 2000 Jul; 85(7):773-4. PubMed ID: 10897139
[No Abstract] [Full Text] [Related]
25. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children.
Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ
Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052
[TBL] [Abstract][Full Text] [Related]
26. Cost of paid transplantation abroad: possible donor-origin early multiple myeloma in a renal transplant recipient treated using bortezomib.
Solak Y; Atalay H; Anil M; Aydogdu I; Tonbul HZ
Transplant Proc; 2010 Sep; 42(7):2813-5. PubMed ID: 20832595
[TBL] [Abstract][Full Text] [Related]
27. EBV-associated recurrent Hodgkin's disease after renal transplantation.
Flanagan KH; Brennan DC
Transpl Int; 2006 Apr; 19(4):338-41. PubMed ID: 16573551
[TBL] [Abstract][Full Text] [Related]
28. Post-transplant lymphoproliferative disorder limited to the skin.
Samolitis NJ; Bharadwaj JS; Weis JR; Harris RM
J Cutan Pathol; 2004 Jul; 31(6):453-7. PubMed ID: 15186434
[TBL] [Abstract][Full Text] [Related]
29. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ
Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
[TBL] [Abstract][Full Text] [Related]
30. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
Mendoza F; Kunitake H; Laks H; Odim J
Pediatr Transplant; 2006 Feb; 10(1):60-6. PubMed ID: 16499589
[TBL] [Abstract][Full Text] [Related]
31. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical analysis and Epstein-Barr virus in the tonsils of transplant recipients and healthy controls.
Mowry SE; Strocker AM; Chan J; Takehana C; Kalantar N; Bhuta S; Shapiro NL
Arch Otolaryngol Head Neck Surg; 2008 Sep; 134(9):936-9. PubMed ID: 18794437
[TBL] [Abstract][Full Text] [Related]
33. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.
Capello D; Rossi D; Gaidano G
Hematol Oncol; 2005 Jun; 23(2):61-7. PubMed ID: 16216037
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus-associated multifocal leiomyosarcomas arising in a cardiac transplant recipient: autopsy case report and review of the literature.
Nur S; Rosenblum WD; Katta UD; Islam H; Brown K; Ramaswamy G
J Heart Lung Transplant; 2007 Sep; 26(9):944-52. PubMed ID: 17845934
[TBL] [Abstract][Full Text] [Related]
35. Anaplastic T large cell lymphoma diagnosed by exfoliative cytology in a post renal transplant patient.
Treaba D; Assad L; Goldberg C; Loew J; Reddy VB; Kluskens L; Gattuso P
Diagn Cytopathol; 2002 Jul; 27(1):35-7. PubMed ID: 12112813
[TBL] [Abstract][Full Text] [Related]
36. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
Maecker B; Jack T; Zimmermann M; Abdul-Khaliq H; Burdelski M; Fuchs A; Hoyer P; Koepf S; Kraemer U; Laube GF; Müller-Wiefel DE; Netz H; Pohl M; Toenshoff B; Wagner HJ; Wallot M; Welte K; Melter M; Offner G; Klein C
J Clin Oncol; 2007 Nov; 25(31):4902-8. PubMed ID: 17971586
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of peripheral blood Epstein-Barr viral load monitoring using polymerase chain reaction in renal transplant recipients.
Toyoda M; Moudgil A; Warady BA; Puliyanda DP; Jordan SC
Pediatr Transplant; 2008 Nov; 12(7):778-84. PubMed ID: 18331541
[TBL] [Abstract][Full Text] [Related]
38. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
Goral S; Felgar R; Shappell S
Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
[TBL] [Abstract][Full Text] [Related]
39. Slc11a1 (formerly Nramp1) polymorphisms and susceptibility to post-transplant lymphoproliferative disease following pediatric liver transplantation.
Barshes NR; Lee TR; Goss JA; Goodpastor SE; Huls MH; Rooney CM; Karpen SJ; Wyllie S
Transpl Infect Dis; 2006 Jun; 8(2):108-12. PubMed ID: 16734634
[TBL] [Abstract][Full Text] [Related]
40. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
Greenfield HM; Gharib MI; Turner AJ; Guiver M; Carr T; Will AM; Wynn RF
Pediatr Blood Cancer; 2006 Aug; 47(2):200-5. PubMed ID: 16206207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
